]>
IRCT20160813029327N19 IRCT 2020-09-07 Islamic Azad University The effect of magnesium in patients with attention deficit hyperactivity disorder ADHD Evaluation of the efficacy of the methylphenidate in combination with magnesium and methylphenidate with placebo in patients with attention deficit hyperactivity disorder 2018-08-06 anticipated 62 Complete https://irct.ir/trial/32814 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: block randomization, Blinding description: Patients and physician will be blind about drug. 3 Attention deficit hyperactivity disorder. Intervention 1: Intervention group: patients will receive 0.3 to 2 mg/kg/day methylphenidate tablet and magnesium at a dose of 125 mg/day for patients less than 35 kg and 250 mg/day for patients more than 35 kg for 8 weeks. Intervention 2: Control group: patients will receive 0.3 to 2 mg/kg/day methylphenidate tablet and placebo for 8 weeks. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no further information
public Ramin Abrishami
#99, the first of Yakhchal Ave., Gholhak, Shariati St.
Tehran Iran (Islamic Republic of) 193956466 +98 21 2264 0051 r_abrishami@iaups.ac.ir Islamic Azad University scientific Mohammad Effatpanah
Enghelab avenue, Tehran University of Medical Sciences.
Tehran Iran (Islamic Republic of) 1417653761 +98 21 2264 0051 m.effatpanah@gmail.com Tehran University of Medical Sciences Iran (Islamic Republic of) Age between 8-16 years old Diagnosis of ADHD by the pediatric psychiatrist Lack of mental retardation No history of epilepsy and seizure Intake methylphenidate tablet as the main method of drug therapy Consent of the patient and parents to participate in the research 8 years 16 years Both Renal failure intolerance to magnesium F90 Attention-deficit hyperactivity disorders Treatment - Drugs Placebo Intervention group: patients will receive 0.3 to 2 mg/kg/day methylphenidate tablet and magnesium at a dose of 125 mg/day for patients less than 35 kg and 250 mg/day for patients more than 35 kg for 8 weeks. Control group: patients will receive 0.3 to 2 mg/kg/day methylphenidate tablet and placebo for 8 weeks Scores in Conner's Parent Rating Scale questionnaire. Timepoint: Before, 4 weeks and 8 weeks after intervention. Method of measurement: Conner's Parent Rating Scale questionnaire. Scores in ADHD Rating Scale questionnaire. Timepoint: Before, 4 weeks and 8 weeks after intervention. Method of measurement: ADHD Rating Scale questionnaire. Islamic Azad University Approved 2018-03-03 Ethics committee of Islamic Azad University of Pharmaceutical Sciences #99, The First of Yakhchal Ave., Gholhak, Shariati St. Tehran Tehran Iran (Islamic Republic of)